Clinical Trials in Congestive Heart Failure: Why Do Studies Report Conflicting Results?
- 1 July 1988
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 109 (1) , 3-5
- https://doi.org/10.7326/0003-4819-109-1-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failurePublished by Elsevier ,2010
- How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind menJournal of the American College of Cardiology, 1987
- Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failureJournal of the American College of Cardiology, 1985
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985
- Oral amrinone for the treatment of chronic congestive heart failure: Results of a multicenter randomized double-blind and placebo-controlled withdrawal studyJournal of the American College of Cardiology, 1984
- Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathyJournal of the American College of Cardiology, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placeboAmerican Heart Journal, 1982
- DOUBLE-BLIND TRIAL OF CHRONIC ORAL BETA BLOCKADE IN CONGESTIVE CARDIOMYOPATHYThe Lancet, 1981
- Importance of Left Ventricular Chamber Size in Determining the Response to Hydralazine in Severe Chronic Heart FailureNew England Journal of Medicine, 1980